186 related articles for article (PubMed ID: 32421774)
1. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.
Mallick P; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M; Moreau M
Toxicol Sci; 2020 Aug; 176(2):460-469. PubMed ID: 32421774
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.
Song G; Moreau M; Efremenko A; Lake BG; Wu H; Bruckner JV; White CA; Osimitz TG; Creek MR; Hinderliter PM; Clewell HJ; Yoon M
Toxicol Sci; 2019 Jun; 169(2):365-379. PubMed ID: 30768128
[TBL] [Abstract][Full Text] [Related]
3. Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.
Mallick P; Moreau M; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M
Toxicol Sci; 2020 Jan; 173(1):86-99. PubMed ID: 31593217
[TBL] [Abstract][Full Text] [Related]
4. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
5. PBPK modeling to support risk assessment of pyrethroid exposure in French pregnant women.
Thépaut E; Bisson M; Brochot C; Personne S; Appenzeller BMR; Zaros C; Chardon K; Zeman F
Environ Res; 2024 Jun; 251(Pt 1):118606. PubMed ID: 38460660
[TBL] [Abstract][Full Text] [Related]
6. Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.
Yoon M; Clewell HJ
Toxicol Res; 2016 Jan; 32(1):15-20. PubMed ID: 26977255
[TBL] [Abstract][Full Text] [Related]
7. Estimating human exposure to pyrethroids' mixtures from biomonitoring data using physiologically based pharmacokinetic modeling.
Quindroit P; Crépet A; Brochot C
Environ Res; 2021 Jan; 192():110281. PubMed ID: 33031810
[TBL] [Abstract][Full Text] [Related]
8. Estimating the cumulative human exposures to pyrethroids by combined multi-route PBPK models: Application to the French population.
Quindroit P; Beaudouin R; Brochot C
Toxicol Lett; 2019 Sep; 312():125-138. PubMed ID: 31077771
[TBL] [Abstract][Full Text] [Related]
9. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
10. Environmentally relevant mixtures in cumulative assessments: an acute study of toxicokinetics and effects on motor activity in rats exposed to a mixture of pyrethroids.
Starr JM; Scollon EJ; Hughes MF; Ross DG; Graham SE; Crofton KM; Wolansky MJ; Devito MJ; Tornero-Velez R
Toxicol Sci; 2012 Dec; 130(2):309-18. PubMed ID: 22872056
[TBL] [Abstract][Full Text] [Related]
11. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
12. Environmentally relevant mixing ratios in cumulative assessments: a study of the kinetics of pyrethroids and their ester cleavage metabolites in blood and brain; and the effect of a pyrethroid mixture on the motor activity of rats.
Starr JM; Graham SE; Ross DG; Tornero-Velez R; Scollon EJ; Devito MJ; Crofton KM; Wolansky MJ; Hughes MF
Toxicology; 2014 Jun; 320():15-24. PubMed ID: 24631210
[TBL] [Abstract][Full Text] [Related]
13. Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposures.
Wason SC; Smith TJ; Perry MJ; Levy JI
Int J Environ Res Public Health; 2012 May; 9(5):1971-83. PubMed ID: 22754485
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of
Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
[No Abstract] [Full Text] [Related]
15. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat.
Mirfazaelian A; Kim KB; Anand SS; Kim HJ; Tornero-Velez R; Bruckner JV; Fisher JW
Toxicol Sci; 2006 Oct; 93(2):432-42. PubMed ID: 16831841
[TBL] [Abstract][Full Text] [Related]
16. Differential lymphatic versus portal vein uptake of the synthetic pyrethroids deltamethrin and cis-permethrin in rats.
Higgins LG; Chatham LR; Tomczynski SL; MacLeod AK; Moreau M; Clewell HJ; Yoon M; Creek MR; Osimitz TG; Lake BG
Toxicology; 2020 Oct; 443():152563. PubMed ID: 32805335
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using a PBPK model.
Tornero-Velez R; Mirfazaelian A; Kim KB; Anand SS; Kim HJ; Haines WT; Bruckner JV; Fisher JW
Toxicol Appl Pharmacol; 2010 Apr; 244(2):208-17. PubMed ID: 20045431
[TBL] [Abstract][Full Text] [Related]
18. Human risk assessment of 4-n-nonylphenol (4-n-NP) using physiologically based pharmacokinetic (PBPK) modeling: analysis of gender exposure differences and application to exposure analysis related to large exposure variability in population.
Jeong SH; Jang JH; Cho HY; Lee YB
Arch Toxicol; 2022 Oct; 96(10):2687-2715. PubMed ID: 35723719
[TBL] [Abstract][Full Text] [Related]
19. Environmentally relevant pyrethroid mixtures: A study on the correlation of blood and brain concentrations of a mixture of pyrethroid insecticides to motor activity in the rat.
Hughes MF; Ross DG; Starr JM; Scollon EJ; Wolansky MJ; Crofton KM; DeVito MJ
Toxicology; 2016 Jun; 359-360():19-28. PubMed ID: 27330022
[TBL] [Abstract][Full Text] [Related]
20. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
